Short-Term Fasting In Glioma Patients Analysis Of Diet Diaries And Metabolic Parameters Of The Ergo2 Trial

Martin Voss,Katharina J Wenger,Nina von Mettenheim,Jörg Bojunga,Manuela Vetter,Bianca Diehl,Kea Franz,Ruediger Gerlach,Michael W Ronellenfitsch,Patrick N Harter,Elke Hattingen,Joachim P Steinbach,Claus Rödel,Johannes Rieger

NEURO-ONCOLOGY（2021）

引用 13|浏览27

暂无评分

摘要

The strict caloric goals of the ERGO2 trial were tolerated well by patients with recurrent brain cancer. The short diet schedule led to significant metabolic changes with low glucose emerging as a candidate marker of better prognosis. The unexpected lower calorie intake of the control group complicates the interpretation of the results. Clinicaltrials.gov number: NCT01754350; Registration: 21.12.2012.

查看译文

关键词

Fasting,Glioblastoma,Glucose,Ketogenic diet,Leptin,Radiation

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要